Management of β-Adrenergic Blocker and Calcium Channel Antagonist Toxicity

Emergency Medicine Clinics of North America

Volumn 25, Issue 2, 2007, Pages 309-331

  Kerns II, William ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ACTIVATED CARBON; ADRENALIN; AMRINONE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHLORIDE; CATECHOLAMINE; DIAZEPAM; DIGITALIS; DILTIAZEM; DOBUTAMINE; DOPAMINE; GLUCONATE CALCIUM; GLUCONIC ACID; IMIPRAMINE; INSULIN; ISOPRENALINE; METOPROLOL; NIFEDIPINE; NORADRENALIN; PROPRANOLOL; PROPRANOLOL DERIVATIVE; RECOMBINANT GLUCAGON; UNINDEXED DRUG; VASOPRESSIN; VERAPAMIL;

ABSENCE OF SIDE EFFECTS; ACIDEMIA; AORTA BALLOON; ASYSTOLE; BRADYCARDIA; CALCIUM SIGNALING; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMA; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG FORMULATION; DRUG INTOXICATION; DRUG MECHANISM; DRUG OVERDOSE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EXTRACORPOREAL CIRCULATION; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PACING; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; HYPERLACTATEMIA; HYPOGLYCEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; LACTIC ACIDOSIS; METABOLIC DISORDER; MONOTHERAPY; NAUSEA AND VOMITING; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PULMONARY ARTERY CATHETER; RESUSCITATION; REVIEW; SHOCK; SIDE EFFECT; SKIN NECROSIS; STOMACH LAVAGE; TISSUE INJURY; TISSUE NECROSIS; TREATMENT FAILURE; VASCULAR RESISTANCE; VOMITING;

EID: 34247609797     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2007.02.001     Document Type: Review

References (153)

1. Kerns W., Kline J., and Ford M.D. Beta-blocker and calcium channel blocker toxicity. Emerg Med Clin North Am 12 (1994) 365-390
2. Watson W.A., Litovitz T.L., Rodgers G.C., et al. 2002 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 21 (2003) 353-421
3. Litovitz T.L., Klein-Schwartz W., Rodgers G.C., et al. 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 20 (2002) 391-452
4. Watson W.A., Litovitz T.L., Klein-Schwartz W., et al. 2003 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 22 (2004) 335-404
5. Watson W.A., Litovitz T.L., Rodgers G.C., et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 23 (2005) 589-666
6. Lai M.W., Klein-Schwartz W., Rodgers G.C., et al. 2005 Annual report of the American Association of Poison Control Centers' National Poisoning and Exposure Database. Clin Toxicol 44 (2006) 803-932
7. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 1368-1377
8. Jones A.E., Tayal V.S., Sullivan D.M., et al. Randomized, controlled trial of immediate versus delayed goal-directed ultrasound to identify the cause of nontraumatic hypotension in emergency department patients. Crit Care Med 32 (2004) 1703-1708
9. Katz A.M. Calcium channel diversity in the cardiovascular system. J Am Coll Cardiol 28 (1996) 522-529
10. Sperelakis N., and Wahler G.M. Regulation of Ca2+ influx in myocardial cells by beta adrenergic receptors, cyclic nucleotides, and phosphorylation. Mol Cell Biochem 82 (1988) 19-28
11. Katz A.M. Selectivity and toxicity of antiarrhythmic drugs: molecular interactions with ion channels. Am J Med 104 (1998) 179-195
12. DeWitt C.R., and Waksman J.C. Pharmacology, pathophysiology, and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev 23 (2004) 223-238
13. Masters T.N., and Glaviano V.V. Effects of d,l-propranolol on myocardial free fatty acid and carbohydrate metabolism. J Pharmacol Exp Ther 167 (1969) 187-193
14. Kline J., Leonova E., and Raymond R.M. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med 23 (1995) 1251-1263
15. Devis G., Somers G., Obberghen E., et al. Calcium antagonists and islet function. I. Inhibition of insulin release by verapamil. Diabetes 24 (1975) 247-251
16. Kline J.A., Raymond R.M., Schroeder J.D., et al. The diabetogenic effects of acute verapamil poisoning. Toxicol Appl Pharmacol 145 (1997) 357-362
17. Weinstein R.S. Recognition and management of poisoning with beta-adrenergic blocking agents. Ann Emerg Med 13 (1984) 1123-1131
18. Ramoska E.A., Spiller H.A., Winter M., et al. A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. Ann Emerg Med 22 (1993) 196-200
19. Smith H.J., and Briscoe M.G. The relative sensitization by acidosis of five calcium blockers in cat papillary muscles. J Mol Cell Cardiol 17 (1985) 1709-1716
20. Tanen D.A., Ruha A.M., Curry S.C., et al. Hypertonic sodium bicarbonate is effective in the acute management of verapamil toxicity in a swine model. Ann Emerg Med 36 (2000) 547-553
21. Holstege C.P., Kirk M.A., Furbee R.B., et al. Wide complex dysrhythmia in calcium channel blocker overdose responsive to sodium bicarbonate therapy. [abstract]. J Toxicol Clin Toxicol 36 (1998) 509
22. Watling S.M., Crain J.L., Edwards T.D., et al. Verapamil overdose: case report and review of the literature. Ann Pharmacother 26 (1992) 1373-1378
23. Enyeart J.J., Price W.A., Hoffman D.A., et al. Profound hyperglycemia and metabolic acidosis after verapamil overdose. J Am Coll Cardiol 2 (1983) 1228-1231
24. Roth A., Miller H.I., Belhassen B., et al. Slow-release verapamil and hyperglycemic metabolic acidosis. Ann Intern Med 110 (1989) 171-172
25. Yuan T.H., Kerns W.P., Tomaszewski C.A., et al. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol 37 (1999) 463-467
26. Rooney M., Massey K.L., Jamali F., et al. Acebutolol overdose treated with hemodialysis and extracorporeal membrane oxygenation. J Clin Pharmacol 36 (1996) 760-763
27. Shore E.T., Cepin D., and Davidson M.J. Metoprolol overdose. Ann Emerg Med 10 (1981) 524-527
28. Buiumsohn A., Eisenberg E.S., Jacob H., et al. Seizures and intraventricular conduction defect in propranolol poisoning. A report of two cases. Ann Intern Med 91 (1979) 860-862
29. Herrington D.M., Insley B.M., and Weinmann G.G. Nifedipine overdose. Am J Med 81 (1986) 344-346
30. Humbert V.H., Munn N.J., and Hawkins R.F. Noncardiogenic pulmonary edema complicating massive diltiazem overdose. Chest 99 (1991) 258-260
31. American Academy of Clinical Toxicology. European Association of Poison Centres and Clinical Toxicologists. Position paper: gastric lavage. J Toxicol Clin Toxicol 42 (2004) 933-943
32. American Academy of Clinical Toxicology. European Association of Poison Centres and Clinical Toxicologists. Position statement: single-dose activated charcoal. J Toxicol Clin Toxicol 35 (1997) 721-741
33. Spiller H.A., Meyers A., Ziemba T., et al. Delayed onset of cardiac arrhythmias from sustained-release verapamil. Ann Emerg Med 20 (1991) 201-203
34. Laine K., Kivisto K.T., and Neuvonen P.J. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil. J Toxicol Clin Toxicol 35 (1997) 263-268
35. American Academy of Clinical Toxicology. European Association of Poison Centres and Clinical Toxicologists. Position paper: whole bowel irrigation. J Toxicol Clin Toxicol 42 (2004) 843-854
36. Buckley N., Dawson A.H., Howarth D., et al. Slow-release verapamil poisoning: use of polyethylene glycol whole bowel irrigation and high-dose calcium. Med J Aust 158 (1993) 202-204
37. Haddad L.M. Resuscitation after nifedipine overdose exclusively with intravenous calcium. Am J Emerg Med 14 (1996) 602-603
38. Hariman R.J., Mangiardi L.M., McAllister R.G., et al. Reversal of the cardiovascular effects of verapamil by calcium and sodium: differences between electrophysiologic and hemodynamic responses. Circulation 59 (1979) 797-804
39. Gay R., Algeo S., Lee R., et al. Treatment of verapamil toxicity in intact dogs. J Clin Invest 77 (1986) 1805-1811
40. Strubelt O., and Diederich K.-W. Experimental investigations of the antidotal treatment of nifedipine overdosage. Clin Toxicol 24 (1986) 135-149
41. Perkins C.M. Serious verapamil poisoning: treatment with intravenous calcium gluconate. Br Med J 2 (1978) 1127
42. Chimienti M., Previtali M., Medici A., et al. Acute verapamil poisoning: successful treatment with epinephrine. Clin Cardiol 5 (1982) 219-222
43. Crump B.J., Holt D.W., and Vale J.A. Lack of response to intravenous calcium in severe verapamil poisoning. Lancet 2 (1982) 939-940
44. Horowitz B.Z., and Rhee K.J. Massive verapamil ingestion: a report of two cases and a review of the literature. Am J Emerg Med 7 (1989) 624-631
45. Li Saw Hee F.L., and Lip G.Y.H. Case report: fatal verapamil overdosage despite intensive therapy and use of high dose intravenous calcium. J Hum Hypertens 10 (1996) 495-496
46. Strubelt O. Evaluation of antidotes against the acute cardiovascular toxicity of propranolol. Toxicology 31 (2006) 261-270
47. Langemeijer J., de Wildt D., de Groot G., et al. Calcium interferes with the cardiodepressive effects of beta-blocker overdose in isolated rat hearts. J Toxicol Clin Toxicol 24 (1986) 111-133
48. Love J.N., Hanfling D., and Howell J.M. Hemodynamic effects of calcium chloride in a canine model of acute propranolol intoxication. Ann Emerg Med 28 (1996) 1-6
49. Jones J.L. Metoprolol overdose. Ann Emerg Med 11 (1982) 114-115
50. Sangster B., de Wildt D., van Dijk A., et al. A case of acebutolol intoxication. J Toxicol Clin Toxicol 20 (1983) 69-77
51. Tai Y.T., Lo C.W., Chow W.H., et al. Successful resuscitation and survival following massive overdose of metoprolol. Br J Clin Pract 44 (1990) 746-747
52. Pertoldi F., D'Olando L., and Mercante W.P. Electromechanical dissociation 48 hours after atenolol overdose: usefulness of calcium chloride. Ann Emerg Med 31 (1998) 777-781
53. Brimacombe J.R., Scully M., and Swainston R. Propranolol overdose-a dramatic response to calcium chloride. Med J Aust 155 (1991) 267-268
54. Cote C.J., Drop L.J., Daniels A.L., et al. Calcium chloride versus calcium gluconate: comparison of ionization and cardiovascular effects in children and dogs. Anesthesiology 66 (1987) 465-470
55. Martin T.J., Kang Y., Robertson K.M., et al. Ionization and hemodynamic effects of calcium chloride and calcium gluconate in the absence of hepatic function. Anesthesiology 73 (1990) 62-65
56. Buckley N., Whyte I.M., and Dawson A.H. Overdose with calcium channel blockers. Br Med J 308 (1994) 1639
57. Carlon G.C., Howland W.S., Goldiner P.L., et al. Adverse effects of calcium administration. Report of two cases. Arch Surg 113 (1978) 882-885
58. Parmley W.W. The role of glucagon in cardiac therapy. N Engl J Med 285 (1971) 801-802
59. Holger J.S., Engebretsen K.M., Obetz C.L., et al. A comparison of vasopressin and glucagon in beta-blocker induced toxicity. Clin Toxicol 44 (2006) 45-51
60. Chernish S.M., Maglinte D.D.T., and Brunelle R.L. The laboratory response to glucagon: dosages used in gastrointestinal examinations. Invest Radiol 23 (1988) 847-852
61. Murad F., and Vaughn M. Effect of glucagon on rat heart adenyl cyclase. Biochem Pharmacol 18 (1969) 1053-1059
62. Levey G.S., Fletcher M.A., Klein I., et al. The characterization of I125-glucagon binding in a solubilized preparation of cat myocardial adenylate cyclase. J Biol Chem 249 (1974) 2665-2673
63. Glick G., Parmley W.W., Wechsler A.S., et al. Glucagon: its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol. Circ Res 22 (1968) 789-799
64. Lucchesi B.R. Cardiac actions of glucagon. Circ Res 22 (1968) 777-787
65. Kosinski E.J., and Malindzak G.S. Glucagon and isoproterenol in reversing propranolol toxicity. Arch Intern Med 132 (1973) 840-843
66. Love J.N., Leasure J.A., Mundt D.J., et al. A comparison of amrinone and glucagon therapy for cardiovascular depression associated with propranolol toxicity in a canine model. J Toxicol Clin Toxicol 30 (1992) 399-412
67. Kerns W., Schroeder J.D., Williams C., et al. Insulin improves survival in a canine model of acute beta-blocker toxicity. Ann Emerg Med 29 (1997) 748-757
68. Toet A.E., Wemer J., Vleeming W., et al. Experimental study of the detrimental effect of dopamine/glucagon combination in d,l-propranolol intoxication. Hum Exp Toxicol 15 (1996) 411-421
69. Adlerfliegel F., Leeman M., Demaeyer P., et al. Sotalol poisoning associated with asystole. Intensive Care Med 19 (1993) 57-58
70. Ehgartner G.R., and Zelinka M.A. Hemodynamic instability following intentional nadolol overdose. Arch Intern Med 148 (1988) 801-802
71. Lewis M., Kallenbach J., Germond C., et al. Survival following massive overdose of adrenergic blocking agents (acebutolol and labetalol). Eur Heart J 4 (1983) 328-332
72. Illingworth R.N. Glucagon for beta-blocker poisoning. Practitioner 223 (1978) 683-685
73. McVey F.K., and Corke C.F. Extracorporeal circulation in the management of massive propranolol overdose. Anaesthesia 46 (1991) 744-746
74. O'Mahony D., O'Leary P., and Molloy M.G. Severe oxprenolol poisoning: the importance of glucagon infusion. Hum Exp Toxicol 9 (1990) 101-103
75. Peterson C.D., Leeder J.S., and Sterner S. Glucagon therapy for beta-blocker overdose. Drug Intell Clin Pharm 18 (1984) 394-398
76. Smith R.C., Wilkinson J., and Hull R.L. Glucagon for propranolol overdose. J Am Med Assoc 254 (1985) 2412
77. Love J.N., Sachdeva D.K., Bessman E.S., et al. A potential role for glucagon in the treatment of drug-induced symptomatic bradycardia. Chest 114 (1998) 323-326
78. Wilkinson J. Beta blocker overdoses. Ann Emerg Med 15 (1986) 982
79. Freestone S., Thomas H.M., Bhamra H.K., et al. Severe atenolol poisoning: treatment with prenalterol. Hum Toxicol 5 (1986) 343-345
80. Gerkin R., and Curry S.C. Significant bradycardia following acute self-poisoning with atenolol. [abstract]. Vet Hum Toxicol 29 (1987) 479
81. Hurwitz M.D., Kallenbach J., and Pincus J.S. Massive propranolol overdose. Am J Med 81 (1986) 1118
82. Perrot D., Bui-Xuan B., Bouffard Y., et al. A case of sotalol poisoning with fatal outcome. J Toxicol Clin Toxicol 26 (1988) 389-396
83. Zaritsky A.L., Horowitz M., and Chernow B. Glucagon antagonism of calcium channel blocker-induced myocardial dysfunction. Crit Care Med 16 (1988) 246-251
84. Stone C.K., May W.A., and Carroll R. Glucagon and phenylephrine combination vs glucagon alone in experimental verapamil overdose. Ann Emerg Med 25 (1995) 369-374
85. Stone C.K., Thomas S.H., Koury S.I., et al. Glucagon and phenylephrine combination vs glucagon alone in experimental verapamil overdose. Acad Emerg Med 3 (1996) 120-125
86. Tuncok Y., Apaydin S., Kalkan S., et al. The effects of amrinone and glucagon on verapamil-induced cardiovascular toxicity in anaesthetized rats. International Journal of Investigative Pathology 77 (1996) 207-212
87. Kline J.A., Tomaszewski C.A., Schroeder J.D., et al. Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine. J Pharmacol Exp Ther 267 (1993) 744-750
88. Jolly S.R., Kipnis J.N., and Lucchesi B.R. Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol. Pharmacology 35 (1987) 249-255
89. Sabatier J., Pouyet T., Shelvey G., et al. Antagonistic effects of epinephrine, glucagon and methylatropine but not calcium chloride against atrio-ventricular conduction disturbances produced by high doses of diltiazem, in conscious dogs. Fundam Clin Pharmacol 5 (1991) 93-106
90. Doyon S., and Roberts J.R. The use of glucagon in a case of calcium channel blocker overdose. Ann Emerg Med 22 (1993) 1229-1233
91. Pollack C.V. Utility of glucagon in the emergency department. J Emerg Med 11 (1993) 195-205
92. Quezado Z., Lippmann M., and Wertheimer J. Severe cardiac, respiratory, and metabolic complications of massive verapamil overdose. Crit Care Med 19 (1991) 436-438
93. Walter F.G., Frye G., Mullen J.T., et al. Amelioration of nifedipine poisoning associated with glucagon therapy. Ann Emerg Med 22 (1993) 1234-1237
94. Wolf L.R., Spadafora M.P., and Otten E.J. Use of amrinone and glucagon in a case of calcium channel blocker overdose. Ann Emerg Med 22 (1993) 1225-1228
95. Erickson F.C., Ling L.J., Grande G.A., et al. Diltiazem overdose: case report and review. J Emerg Med 9 (1991) 357-366
96. Williams J.F., Childress R.H., Chip J.N., et al. Hemodynamic effects of glucagon in patients with heart disease. Circulation 39 (1969) 38-47
97. vander Ark C.R., and Reynolds E.W. Clinical evaluation of glucagon by continuous infusion in the treatment of low cardiac output states. Am Heart J 79 (1970) 481-487
98. Hall-Boyer K., Zaloga G.P., and Chernow B. Glucagon: hormone or therapeutic agent?. Crit Care Med 12 (1984) 584-589
99. Love J.N., and Tandy T.K. Beta-adrenoceptor antagonist toxicity: a survey of glucagon availability. Ann Emerg Med 22 (1993) 267-268
100. Donovan K.D., Gerace R.V., and Dreyer J.F. Acebutolol-induced ventricular tachycardia reversed with sodium bicarbonate. J Toxicol Clin Toxicol 37 (1999) 481-484
101. Lindvall K., and Sojgren A. High-dose prenalterol in beta-blockade intoxication. Acta Med Scand 218 (1985) 525-528
102. Goenen M., Col J., Compere A., et al. Treatment of severe verapamil poisoning with combined amrinone-isoproterenol therapy. Am J Cardiol 58 (1986) 1142-1143
103. Avery G.J., Spotnitz H.M., Rose E.A., et al. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration. J Thorac Cardiovasc Surg 77 (1979) 267-276
104. Richards D.A., Prichard B.N., Boakes A.J., et al. Pharmacological basis for antihypertensive effects of intravenous labetalol. Br Heart J 39 (1977) 99-106
105. Anthony T., Jastremski M., Elliott W., et al. Charcoal hemoperfusion for the treatment of a combined diltiazem and metoprolol overdose. Ann Emerg Med 15 (1986) 1344-1348
106. Koch A.R., Vogelaers G.P., Decruyenaere J.M., et al. Fatal intoxication with amlodipine. J Toxicol Clin Toxicol 33 (1995) 253-256
107. Hoffman B.B., and Lefkowitz R.J. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman J.G., Limbird L.E., Molinoff P.B., et al. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics (1996), McGraw-Hill, New York 199-248
108. Weissler A.M., Altschuld R.A., Gibb L.E., et al. Effect of insulin on the performance and metabolism of the anoxic isolated perfused rat heart. Circ Res 32 (1973) 108-116
109. Farah A.E., and Alousi A.A. The actions of insulin on cardiac contractility. Life Sci 29 (1981) 975-1000
110. Reikeras O., Gunnes P., Sorlie D., et al. Metabolic effects of high doses of insulin during acute left ventricular failure in dogs. Eur Heart J 6 (1985) 451-457
111. Law W.R., McLane M.P., and Raymond R.M. Effect of insulin on myocardial contractility during canine endotoxin shock. Cardiovasc Res 22 (1988) 777-785
112. Raymond R.M., McLane M.P., Law W.R., et al. Myocardial insulin resistance during acute endotoxin shock in dogs. Diabetes 37 (1988) 1684-1688
113. Kline J.A., Raymond R.M., Leonova E., et al. Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines. Cardiovasc Res 34 (1997) 289-298
114. Spurlock B.W., Virani N.A., and Henry C.A. Verapamil overdose. West J Med 154 (1991) 208-211
115. Howard D.C. Glucagon for reaction to combined calcium channel blocker and beta-blocker use. J Emerg Nurs 22 (1996) 173-175
116. Kline J.A., Leonova E., Williams T.C., et al. Myocardial metabolism during graded intraportal verapamil infusion in awake dogs. J Cardiovasc Pharmacol 27 (1996) 719-726
117. Place R., Carlson A., Leiken J., et al. Hyperinsulin therapy in the treatment of verapamil overdose. [abstract]. J Toxicol Clin Toxicol 38 (2000) 576-577
118. Boyer E.W., Duic P.A., and Evans A. Hyperinsulinemia/euglycemia therapy for calcium channel blocker poisoning. Pediatr Emerg Care 18 (2002) 36-37
119. Boyer E.W., and Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. N Engl J Med 344 (2001) 1721-1722
120. Herbert J.X., O'Malley C., Tracey J.A., et al. Verapamil overdosage unresponsive to dextrose/insulin therapy. [abstract]. J Toxicol Clin Toxicol 39 (2001) 293-294
121. Cumpston K., Mycyk M., Pallasch E., et al. Failure of hyperinsulinemia/euglycemia therapy in severe diltiazem overdose. [abstract]. J Toxicol Clin Toxicol 40 (2002) 618
122. Marques M., Gomes E., and de Oliviera J. Treatment of calcium channel blocker intoxication with insulin infusion: case report and literature review. Resuscitation 57 (2003) 211-213
123. Rasmussen L., Husted S.E., and Johnsen S.P. Severe intoxication after an intentional overdose of amlodipine. Acta Anaesthesiol Scand 47 (2003) 1038-1040
124. Meyer M., Stremski E., and Scanlon M. Verapamil-induced hypotension reversed with dextrose-insulin. [abstract]. J Toxicol Clin Toxicol 39 (2001) 500
125. Marraffa J.M., Stork C.M., Medicis J.J., et al. Massive amlodipine overdose successfully treated using high-dose vasopressin. [abstract]. J Toxicol Clin Toxicol 42 (2004) 732-733
126. Greene S.L., Gawarammana I.B., Dargan P.I., et al. Safety of high dose insulin therapy in calcium channel antagonist overdose. [abstract]. J Toxicol Clin Toxicol 44 (2006) 758
127. Miller A.D., Maloney G.E., Kanter M.Z., et al. Hypoglycemia in patients treated with high-dose insulin for calcium channel blocker poisoning. [abstract]. J Toxicol Clin Toxicol 44 (2006) 782-783
128. Harris N.S. Case records of the Massachusetts General Hospital. Case 24-2006. A 40-year-old woman with hypotension after an overdose of amlodipine. N Engl J Med 355 (2006) 602-611
129. Kebler R., McDonald F.D., and Cadnapaphornchai P. Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. Am J Med 79 (1985) 571-576
130. Ionescu-Tirgoviste C., Bruckner I., Mihalache N., et al. Plasma phosphorus and magnesium values during treatment of severe diabetic ketoacidosis. Med Interne 19 (1981) 66-68
131. Frishman W.H. Beta-adrenergic blockers. Med Clin North Am 72 (1988) 37-81
132. Nicolas F., Villers D., Rozo L., et al. Severe self-poisoning with acebutolol in association with alcohol. Crit Care Med 15 (1987) 173-174
133. Offenstadt G., Hericord P., and Amstutz P. Intoxication volontaire par le pindolol [Intentional overdose of pindolol]. Nouv Presse Med 5 (1976) 1539
134. Rosen M.R., Ilvento J.P., Gelband H., et al. Effects of verapamil on electrophysiologic properties of canine cardiac Purkinje fibers. J Pharmacol Exp Ther 189 (1974) 414-422
135. Henry P.D. Comparative pharmacology of calcium antagonists: nifedipine, verapamil, and diltiazem. Am J Cardiol 46 (1980) 1047-1058
136. Yatani A., and Brown A.M. The calcium channel blocker nitrendipine blocks sodium channels in neonatal rat cardiac myocytes. Circ Res 57 (1985) 868-875
137. Prakash P., and Tripathi O. Verapamil and TTX inhibit +Vmax but differentially alter the duration of action potential of adult chicken ventricular myocardium. Indian J Biochem Biophys 35 (1998) 123-130
138. Love J.N., Howell J.M., Newsome J.T., et al. The effect of sodium bicarbonate on propranolol-induced cardiovascular toxicity in a canine model. J Toxicol Clin Toxicol 38 (2000) 421-428
139. Brubacher J.R. Beta-adrenergic antagonists. In: Goldfrank L.R., Flomenbaum N.E., Lewin N.A., et al. (Eds). Goldfrank's toxicologic emergencies (2002), McGraw-Hill, New York 741-761
140. Saitz R., Williams B.W., and Farber H.W. Atenolol-induced cardiovascular collapse treated with hemodialysis. Crit Care Med 19 (1991) 116-118
141. Salhanick S.D., and Wax P.M. Treatment of atenolol overdose in a patient with renal failure using serial hemodialysis and hemoperfusion and associated echocardiographic findings. Vet Hum Toxicol 42 (2000) 224-225
142. Kenyon C.J., Aldinger G.E., Joshipura P., et al. Successful resuscitation using external cardiac pacing in beta adrenergic antagonist-induced bradyasystolic arrest. Ann Emerg Med 17 (1988) 711-713
143. Ehara T., and Daufmann R. The voltage- and time-dependent effects of (-)-verapamil on the slow inward current in isolated cat ventricular myocardium. J Pharmacol Exp Ther 207 (1978) 49-55
144. Holzer M., Sterz F., Schoerkhuber W., et al. Successful resuscitation of a verapamil-intoxicated patient with percutaneous cardiopulmonary bypass. Crit Care Med 27 (1999) 2818-2823
145. Hendren W.G., Schieber R.S., and Garrettson L.K. Extracorporeal bypass for the treatment of verapamil poisoning. Ann Emerg Med 18 (1989) 984-987
146. Lane A.S., Woodward A.C., and Goldman M.R. Massive propranolol overdose poorly responsive to pharmacologic therapy: use of the intra-aortic balloon pump. Ann Emerg Med 16 (1987) 1381-1383
147. Frierson J., Bailly D., Shultz T., et al. Refractory cardiogenic shock and complete heart block after unsuspected verapamil-SR and atenolol overdose. Clin Cardiol 14 (1991) 933-935
148. Hill R.E., Heard K., Bogdan G.M., et al. Attenuation of verapamil-induced myocardial toxicity in an ex-vivo rat model using a verapamil-specific ovine immunoglobin. Acad Emerg Med 8 (2001) 950-955
149. Tebbutt S., Harvey M., Nicholson T., et al. Intralipid prolongs survival in a rat model of verapamil toxicity. Acad Emerg Med 13 (2006) 134-139
150. Noguera I., Medina P., Segarra G., et al. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery. Br J Pharmacol 122 (1997) 1315-1320
151. Holstege C.P., Hunter Y., Baer A.B., et al. Massive caffeine overdose requiring vasopressin infusion and hemodialysis. J Toxicol Clin Toxicol 41 (2003) 1003-1008
152. Sztajnkrycer M.D., Bond G.R., Johnson S.B., et al. Use of vasopressin in a canine model of severe verapamil poisoning: a preliminary descriptive study. Acad Emerg Med 11 (2004) 1253-1261
153. Barry J.D., Durkovich D.W., Richardson W., et al. Vasopressin treatment of verapamil toxicity in the porcine model. J Med Toxicol 1 (2005) 3-10